期刊文献+

C-反应蛋白与糖尿病视网膜病变的关系

C-reactive protein and type 2 diabetic retinopathy
暂未订购
导出
摘要 目的探讨2型糖尿病患者中C-反应蛋白(CRP)与糖尿病视网膜病变(DR)的关系。方法速粒散射比法测定48例糖尿病无DR对照组、48例糖尿病DR患者的血清CRP、HbAlt水平,比较组间差异及血清CRP、HbAlt水平与DR病变程度的相关性。结果DR组的血清CRP水平高于对照组,差异有显著性(P<0.05);CRP、HbAlt水平在DRⅠ期、Ⅱ期、Ⅲ期、Ⅳ期组逐渐增高,差异有显著性(P<0.05)CRP、HbAlt水平与DR病变程度呈正相关。结论CRP水平在对照组、DRⅠ期、Ⅱ期、Ⅲ期、Ⅳ期组逐渐增高,表明其可能是2型DM患者DR发生、发展的危险因素;在一定程度上能够预侧2型糖尿病患者发生DR的风险并估计其严重程度。 Objective To clarify the relationship between C-reactive protein (CRP) and diabetic retinopathy. Methods We assayed serum CRP concentration and HbAlc in 48 diabetes patients without DR controls and 48 trpe 2 diabetes patients with DR (9 stage Ⅰ ,15stage Ⅱ ,17 stage Ⅲ,7 stage Ⅳ).Results CRP concentration was higher in DR group than control(P 〈 0.05),CRP concentration rise with DR stage ( P 〈 0.05), highest in stage Ⅳ DR. Conclusion Higher serum CRP concentration in patients of DM and DR may be a risk factor that give rise to DM and DR. CRP, to some extent,could predict the oceuremce risk of DR in type 2 diabetic patients.
作者 王贺元 刘艳
出处 《中国实验诊断学》 2008年第8期990-992,共3页 Chinese Journal of Laboratory Diagnosis
关键词 糖尿病 C一反应蛋白 糖尿病视网膜病变 diabetes C-reactive protein diabetic retinopathy
  • 相关文献

参考文献2

二级参考文献59

  • 1Zairis MN, Ambrose JA, Manousakis SJ, et al. The impact of plasma levels of C-reactive protein, lipoprotein(a) and homocysteine on the long-term prognosis after successful coronary stenting: The Global Evaluation of New Events and Restenosis After Stent Implantation Study. J Am Coll Cardiol 2002 40(8):1375-82.
  • 2Zebrack JS, Muhlestein JB, Home BD, et al. C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. J Am Coll Cardiol 2002: 39:632 - 7.
  • 3Fadl YY, Zareba W, Moss A J, et al. History of hypertension and enhanced thrombogenie activity in postinfarction patients. Hypertertsion 2003:41 (4): 943 - 9.
  • 4Saito M, lshirnitsu T, Minami J, et al. Rehtions of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors. Atherosclerosis 2003:167(1):73 -9.
  • 5Thorand B, Lowel H, Schneider A, et al. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998. Arch Intern Med 2003; 163(1 ): 93 - 9.
  • 6Ansell B J, Watson KE, Weiss RE, et aL hsCRP and HDI. Effects of Statins Trial (CHEST): Rapid Effect of Statin Therapy on C-Reactive Protein and High-Density Lipoprotein Levels A Clinical Investigation. Heart Dis 2003; 5 (1): 2 - 7.
  • 7Plenge JK. Hernandez TL, Weil KM. et al. Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction. Circulation 2002; 106 (12) : 1447 - 52.
  • 8Swinburn JM, Stubbs P, Soman P, et al. Rapid assessment of patients with non-ST-segment elevat on acute chest pain: troponins, inflammatory, markers, or perfusion imaging? J Nucl Cardiol 2002 ; 9 (5) : 491 - 9.
  • 9Jenkins NP, ChB MB, Keevil BG, et al. Beta-blockers are associated with lower C-reactive protein concentrations in patients with coronarv artery disease. Am J Med 2002; 112:269 - 74 .
  • 10Gornikiewicz A, Sautner T, Brostjan C, et al. Catecholamines upregulate lipopolysaccharide-induced IL-6 production in human microvascular endothelial cells. FASEB J 2000;9:1093 - lO0.

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部